Philip P Boudreau insider trades

Open-market stock purchases and sales by Philip P Boudreau, EVP AND CFO at Abbott Laboratories, from SEC Form 4 filings since Mar 13, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +11%.

Recent trades

DateStockTradeValue
Sep 1, 2026ABT Abbott LaboratoriesSold (not open market)$42.8K
Apr 23, 2026ABT Abbott LaboratoriesBought (not open market)$820K
Apr 23, 2026ABT Abbott LaboratoriesBought$201K
Feb 27, 2026ABT Abbott LaboratoriesSold (not open market)$865K
Feb 24, 2026ABT Abbott LaboratoriesBought (not open market)—
Feb 24, 2026ABT Abbott LaboratoriesBought (not open market)—

Companies traded

  • ABT Abbott Laboratories: 1 buy, 4 sales, last Sep 1, 2026

Get free alerts when Philip P Boudreau files a new trade →